Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography.

OBJECTIVES Our goal was to validate myocardium at risk on T2-weighted short tau inversion recovery (T2-STIR) cardiac magnetic resonance (CMR) over time, compared with that seen with perfusion single-photon emission computed tomography (SPECT) in patients with ST-segment elevation myocardial infarction, and to assess the amount of salvaged myocardium after 1 week. BACKGROUND To assess reperfusion therapy, it is necessary to determine how much myocardium is salvaged by measuring the final infarct size in relation to the initial myocardium at risk of the left ventricle (LV). METHODS Sixteen patients with first-time ST-segment elevation myocardial infarction received (99m)Tc tetrofosmin before primary percutaneous coronary intervention. SPECT was performed within 4 h and T2-STIR CMR within 1 day, 1 week, 6 weeks, and 6 months. At 1 week, patients were injected with a gadolinium-based contrast agent for quantification of infarct size. RESULTS Myocardium at risk at occlusion on SPECT was 33 +/- 10% of the LV. Myocardium at risk on T2-STIR did not differ from SPECT, at day 1 (29 +/- 7%, p = 0.49) or week 1 (31 +/- 6%, p = 0.16) but declined at week 6 (10 +/- 12%, p = 0.0096 vs. 1 week) and month 6 (4 +/- 11%, p = 0.0013 vs. 1 week). There was a correlation between myocardium at risk demonstrated by T2-STIR at week 1 and myocardium at risk by SPECT (r(2) = 0.70, p < 0.001), and the difference between the methods on Bland-Altman analysis was not significant (-2.3 +/- 5.7%, p = 0.16). Both modalities identified myocardium at risk in the same perfusion territory and in concordance with angiography. Final infarct size was 8 +/- 7%, and salvage was 75 +/- 19% of myocardium at risk. CONCLUSIONS This study demonstrates that T2-STIR performed up to 1 week after reperfusion can accurately determine myocardium at risk as it was before opening of the occluded artery. CMR can also quantify salvaged myocardium as myocardium at risk minus final infarct size.

[1]  D D Watson,et al.  Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. , 1990, Circulation.

[2]  J. Schulz-Menger,et al.  Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction , 2004, Circulation.

[3]  M. Fishbein,et al.  The histopathologic evolution of myocardial infarction. , 1978, Chest.

[4]  R. Guyton,et al.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.

[5]  G. Adam,et al.  Characterization of the peri-infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction , 2006, European Radiology.

[6]  Einar Heiberg,et al.  An Improved Method for Automatic Segmentation of the Left Ventricle in Myocardial Perfusion SPECT , 2009, Journal of Nuclear Medicine.

[7]  E. McVeigh,et al.  T2‐prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo , 2007, Magnetic resonance in medicine.

[8]  J. Gili,et al.  Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. , 1993, Cardiovascular research.

[9]  Einar Heiberg,et al.  Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. , 2008, Radiology.

[10]  Tomio Inoue,et al.  Diagnostic use of T2-weighted inversion-recovery magnetic resonance imaging in acute coronary syndromes compared with 99mTc-Pyrophosphate, 123I-BMIPP and 201TlCl single photon emission computed tomography. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[11]  L. Shaw,et al.  Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: A comparison between 99mTc-tetrofosmin and 99mTc-sestamibi , 2007, Nuclear medicine communications.

[12]  R. Jennings,et al.  Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. , 1985, Circulation research.

[13]  E. Braunwald,et al.  Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. , 1998, Circulation.

[14]  C. Higgins,et al.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. , 1999, Radiology.

[15]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[16]  J. Lowe,et al.  Experimental infarct size as a function of the amount of myocardium at risk. , 1978, The American journal of pathology.

[17]  A. Jaffe,et al.  The quantification of infarct size. , 2004, Journal of the American College of Cardiology.

[18]  Andrew E Arai,et al.  In Vivo T2-Weighted Magnetic Resonance Imaging Can Accurately Determine the Ischemic Area at Risk for 2-Day-Old Nonreperfused Myocardial Infarction , 2008, Investigative radiology.

[19]  Tomio Inoue,et al.  Diagnostic Use of T 2-Weighted Inversion – Recovery Magnetic Resonance Imaging in Acute Coronary Syndromes Compared With 99 mTc-Pyrophosphate , 123 I-BMIPP and 201 TlCl Single Photon Emission Computed Tomography , 2004 .

[20]  R. Gibbons,et al.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. , 1989, Circulation.

[21]  C. White,et al.  The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. , 1987, Circulation.

[22]  Peter Kellman,et al.  ACUT2E TSE‐SSFP: A hybrid method for T2‐weighted imaging of edema in the heart , 2008, Magnetic resonance in medicine.

[23]  B. Gersh.  Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage: Analysis of Ischemic Myocardium at Risk Using Cardiac Magnetic Resonance , 2008 .

[24]  C. Higgins,et al.  Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. , 2000, Radiology.

[25]  R. F. Hoyt,et al.  Cardiac magnetic resonance imaging , 2004, Postgraduate Medical Journal.

[26]  C. Higgins,et al.  Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging. , 1989, Radiology.

[27]  G. Adam,et al.  Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarction , 2007, European Radiology.

[28]  W. Wijns,et al.  Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. , 1990, Circulation.

[29]  J. Schulz-Menger,et al.  The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[30]  J. Lowe,et al.  The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.

[31]  Marcus Carlsson,et al.  Magnetic resonance imaging as a potential gold standard for infarct quantification. , 2008, Journal of electrocardiology.